Gilead Sciences Inc (NASDAQ:GILD)

U.S. Markets are not yet open, but GILD is being traded in the pre-market session. Pre-Market quote »
115.66
Delayed Data
As of Jul 06
 +0.62 / +0.54%
Today’s Change
84.75
Today|||52-Week Range
123.37
+22.70%
Year-to-Date

Today’s Trading

Previous close115.04
Today’s open114.46
Day’s range114.12 - 116.44
Volume13,543,318
Average volume (3 months)10,965,388
Market cap$169.1B
Dividend yield1.49%
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+32.36%
Earnings growth (next 5 years)+11.10%
Revenue growth (last year)+121.81%
P/E ratio13.2
Price/Sales6.24
Price/Book11.18

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.24+0.81%
BIIBBiogen+0.35+0.09%
BXLTBaxalta Inc+0.68+2.19%
BAXBaxter International...-0.26-0.68%
Data as of 07/06/2015

Financials

Next reporting dateJuly 23, 2015
EPS forecast (this quarter)$2.64
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers